Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: Does it influence cerebral hemodynamics?
It is well known that red blood cells incubated in low-density lipoprotein (LDL)-rich medium show shape abnormalities that revert to normal after reincubation in normal plasma. Patients with homozygous familial hypercholesterolemia (HFH) have an increased percentage of abnormally-shaped erythrocytes (mostly stomatocytes, knisocytes, and crenated cells) compared to normocholesterolemic controls: 7.73±0.96 versus 3.52±0.52 (mean±SEM;P=0.001). To confirm the role of high LDL concentration in inducing red cell shape abnormalities we determined the percentage of abnormally shaped erythrocytes in seven HFH patients 1 day after the procedure of LDL-apheresis with a 40% cholesterol decrease. A reduction in kniscocytes, stomatocytes, and crenated cells was observed in the patients treated by LDL-apheresis (P<0.01).
To investigate the possible benefit of a reduction in erythrocyte shape abnormality on cerebral hemodynamics, cerebral flow velocity, as evaluated by transcranial Doppler, was evaluated concommitanlly and found to be remarkably increased after apheresis (P<0.01). No significant change in hematocrit, plasma viscosity, blood viscosity, mean pressure, or cardiac output was detected, 1 day after apheresis. An inverse correlation was demonstrated (r=0.55;P=0.04) between changes in the percentage of knisocytes+stomatocytes+crenated cells and percent changes in middle cerebral artery peak systolic velocity. The correction of erythrocyte shape abnormalities after LDL-apheresis might be related to dramatic changes in plasma phospholipid concentration and proportion occurring after this procedure in HFH patients. The reduction of erythrocyte shape abnormalities could contribute, together with other hemorheological factors, to the improvement of cerebral hemodynamics after LDL-apheresis.
Key wordsErythrocyte shape Familial hypercholesterolemia LDL-apheresis Blood component removal Cerebral flow velocity Transcranial Doppler Cholesterol
Unable to display preview. Download preview PDF.
- 3.Huy DY, Harmony JAK (1978) Interaction of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphology. Biochim Biophys Acta 550:407–424Google Scholar
- 9.Rubba P, Faccenda F, DiSomma S, Gnasso A, Scarpato N, Iannuzzi A, Nappi G, Postiglione A, DeDivitiis O, Mancini M (1993) Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia. Stroke 24:1154–1161PubMedGoogle Scholar
- 10.Schuff-Werner P, Schutz E, Seide WC, Eisenhauer TH, Janning G, Armstrong VW, Seidel D (1989) Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest 19:30–37PubMedGoogle Scholar
- 12.Montefusco S, Gnasso A, Scarpato N, Rubba P, Nappi G, Cortese C, Pandolfi G, Postiglione A (1989) Hemorheological effects of LDL-apheresis in familial hypercholesterolemia. Clin Hemorheol 9:81–87Google Scholar
- 17.Otis SM, Ringelstein EB (1989) Principles and applications of transcranial Doppler sonography. In: Bernstein EF (ed) Non-invasive diagnostic techniques for vascular diagnosis. CV Mosby, St. Louis, pp 59–79Google Scholar
- 18.Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Biochem 19:838–839Google Scholar
- 19.Wahlefeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Academic New York, pp 1831–1974Google Scholar
- 20.Glantz SA (1992) Primer of biostatistics, 3rd edn. McGraw-Hill, New YorkGoogle Scholar
- 21.Glantz SA, Slinker BK (1990) Primer of applied Regression and analysis of variance. Mc-Graw-Hill, New YorkGoogle Scholar
- 24.Engelmann B, Streich S, Schonthier UM, Richter WO, Duhm J (1992) Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. Increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacylglycerol-rich lipoproteins. Biochim Biophys Acta 1165:32–37PubMedGoogle Scholar
- 25.Kulschar R, Engelmann B, Brautigam C, Duhm J, Thiery J, Richeter WO (1995) Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lysophosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis. Eur J Clin Invest 25:258–265PubMedGoogle Scholar
- 27.Huy DY, Harmony JAK (1978) Interaction of plasma lipoproteins with erythrocytes. II. Modulation of membrane-associated enzymes. Biochim Biophys Acta 550:425–434Google Scholar
- 29.Luly P (1989) Membrane lipid changes in the abnormal red cell. In: Raess BU, Tunnicliff G (eds) The red cell membrane. Humana, Clifton, NJ, pp 399–421Google Scholar
- 30.Engelmann B, Brautigam C, Kulschar R, Duhm J, Prenner E, Hermetter A, Richter WO, Thiery J, Seidel D (1994) Reversible reduction of phospholipid-bound arachidonic acid after low-density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane. Biochim Biophys Acta 1196:154–164PubMedCrossRefGoogle Scholar
- 33.Coull BM, Beamer NB, Seaman GVF, Illingworth RD (1987) Hemorheological profile in patients with familial hypercholesterolemia: Effect of lipid-lowering therapy. Clin Hemorheol 7:468Google Scholar
- 36.Beigel Y, Fuchs J, Snir M, Green P, Lurie Y, Djaldetti M (1991) Lovastatin therapy in hypercholesterolemia: Effect on fibrinogen, hemorheologic parameters, platelet activity, and red blood cell morphology. J Clin Pharmacol 6:512–517Google Scholar
- 37.Adams RJ, Nichols FT, Hess DC (1992) Normal values and physiological variables. In Newell DW, Aaslid R (eds) Transcranial Doppler. Raven, New York, pp 41–48Google Scholar
- 39.Bing RJ, Menon M (1990) Vascular relaxation by lysophosphatidylcholine. Relation to nitric oxide production. In: Rubanyi GM, Vanhoutte PM (eds) Endothelium-derived relaxing factors. Karger, Basel, pp 46–54Google Scholar